Prognostic significance of serial changes in left ventricular mass in essential hypertension
- PMID: 9443431
- DOI: 10.1161/01.cir.97.1.48
Prognostic significance of serial changes in left ventricular mass in essential hypertension
Abstract
Background: Increased left ventricular (LV) mass predicts an adverse outcome in patients with essential hypertension. The purpose of this study was to determine the relation between changes in LV mass during antihypertensive treatment and subsequent prognosis.
Methods and results: Procedures including echocardiography and 24-hour ambulatory blood pressure (BP) monitoring were performed in 430 patients with essential hypertension before therapy and after 1217 patient-years. Months or years after the follow-up visit, 31 patients suffered a first cardiovascular morbid event. The patients with a decrease in LV mass from the baseline to follow-up visit were compared with those with an increase in LV mass. There were 15 events (1.78 per 100 person-years) in the group with a decrease in LV mass and 16 events (3.03 per 100 person-years) in the group with an increase in LV mass (P=.029). In a Cox model, the lesser cardiovascular risk in the group with a decrease in LV mass (hazard ratio [HR], 0.46; 95% CI, 0.22 to 0.99) remained significant (P=.04) after adjustment for age (HR, 1.06; 95% CI, 1.03 to 1.10; P=.0008) and baseline LVH at ECG (HR, 3.85; 95% CI, 1.52 to 9.78; P=.012). In that model, baseline LV mass bordered on statistical significance (HR, 1.01; 95% CI, 1.00 to 1.03; P=.06). In the subset with LV mass > 125 g/m2 at the baseline visit (26% of subjects), the event rate was lower among the subjects who achieved regression of LVH than in those who did not (1.58 versus 6.27 events per 100 person-years; P=.002). This difference held in the multivariate analysis (HR, 0.18; 95% CI, 0.05 to 0.68).
Conclusions: In essential hypertension, a reduction in LV mass during treatment is a favorable prognostic marker that predicts a lesser risk for subsequent cardiovascular morbid events. Such an association is independent of baseline LV mass, baseline clinic and ambulatory BP, and degree of BP reduction.
Similar articles
-
Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.Am J Hypertens. 2008 Apr;21(4):464-70. doi: 10.1038/ajh.2008.2. Epub 2008 Feb 7. Am J Hypertens. 2008. PMID: 18369364
-
Prognostic significance of left ventricular mass change during treatment of hypertension.JAMA. 2004 Nov 17;292(19):2350-6. doi: 10.1001/jama.292.19.2350. JAMA. 2004. PMID: 15547162 Clinical Trial.
-
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.Am J Hypertens. 2006 May;19(5):493-9. doi: 10.1016/j.amjhyper.2005.10.018. Am J Hypertens. 2006. PMID: 16647622
-
Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.J Electrocardiol. 2014 Sep-Oct;47(5):630-5. doi: 10.1016/j.jelectrocard.2014.07.003. Epub 2014 Jul 3. J Electrocardiol. 2014. PMID: 25052475 Review.
-
Left ventricular hypertrophy: how to influence an important risk factor in hypertension.J Hypertens Suppl. 1998 Jan;16(1):S53-8. J Hypertens Suppl. 1998. PMID: 9534098 Review.
Cited by
-
24-h central pressure is a valuable predictor for left ventricular hypertrophy in non-dialysis patients with chronic kidney disease.Hypertens Res. 2024 Jun;47(6):1697-1706. doi: 10.1038/s41440-024-01654-2. Epub 2024 Mar 29. Hypertens Res. 2024. PMID: 38553645
-
Regression of left ventricular hypertrophy.Hypertens Res. 2024 May;47(5):1225-1226. doi: 10.1038/s41440-024-01634-6. Epub 2024 Mar 11. Hypertens Res. 2024. PMID: 38467796 No abstract available.
-
Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: Insight from the Korean Hypertension Cohort Study.J Clin Hypertens (Greenwich). 2022 Nov;24(11):1451-1460. doi: 10.1111/jch.14583. Epub 2022 Oct 21. J Clin Hypertens (Greenwich). 2022. PMID: 36268774 Free PMC article.
-
A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure.Med Princ Pract. 2022;31(5):454-462. doi: 10.1159/000526792. Epub 2022 Aug 31. Med Princ Pract. 2022. PMID: 36044874 Free PMC article. Review.
-
Morphological and functional cardiac consequences of rapid hypertension treatment: a cohort study.J Cardiovasc Magn Reson. 2021 Oct 25;23(1):122. doi: 10.1186/s12968-021-00805-5. J Cardiovasc Magn Reson. 2021. PMID: 34689818 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical